Symbol
ABUS on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Shares, without par value
Latest Disclosed Ownership
38.8M shares
Security Ownership
20.5%

Roivant Sciences Ltd. ownership in Arbutus Biopharma Corp Common Shares, without par value (ABUS)

2025-02-25 - Roivant Sciences Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 38.8M shares of Arbutus Biopharma Corp Common Shares, without par value (ABUS). This represents 20.5% percent ownership of the company.